Cannabis Policy
Federal Scientists Outline the Challenges Facing Clinical Cannabis Research in New Paper
The challenges include the complex regulatory status of cannabis, sourcing high-quality cannabis products for study, and issues surrounding funding and support for newer researchers.
Michigan Cannabis Recall Partially Reversed After Lab Wins Claim
The Michigan lab has effectively won half of its claim against the state regulator, ending half of the recall order.
THC Blood Levels and Saliva Are Poor Measures of Cannabis Impairment, Review Finds
The THC levels found in a person’s blood and saliva aren’t good indicators of whether that person is intoxicated or not, according to a new review of studies.
ASTM Publishes White Paper on Delta-8 THC
The leading US testing standards organization ASTM International has released a white paper on delta-8 THC and the testing standards it mandates.
New Report Urges UK to Capitalize on Potential £1.2 Billion Medical Cannabis Market
The United Kingdom could create 41,000 jobs if it properly supported the medical cannabis sector, according to a new report from the drug policy advocacy group Volteface.
More People Are Microdosing Psychedelics, World Drug Survey Finds
Around the world, it seems people are microdosing psychedelics more, and consuming other drugs like cocaine, alcohol, and cannabis less.
Michigan Regulators Recall Cannabis Products Due to Testing Concerns
Authorities in Michigan have recalled all marijuana products – except for inhalable concentrates – tested by Viridis Laboratories, a cannabis lab company in Michigan.
Germany Set to Legalize Cannabis, as Incoming Coalition Reaches Agreement
The three parties expected to form the country’s next government have reportedly agreed to the drug policy.
Canadian Study Finds No Increase in Traffic Accidents After Cannabis Legalization
Cannabis legalization in Canada has not led to any associated increase in the number of traffic accident injuries, a new study has found.
